Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuma Motomura

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Endocrine Journal|May 13, 2026
Anti-pituitary-specific transcription factor-1 hypophysitis developing after thymoma resection: a case report with review of literatureHitomi Konishi, Yui Yamashita, Yuma Motomura, et al.
Endocrine|July 22, 2024
Diagnostic dilemma in Cushing's syndrome: discrepancy between patient-reported and physician-assessed manifestationsYuma Motomura, Shin Urai, Hironori Bando, et al.
Diabetology International|January 24, 2024
Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumabYuma Motomura, Shin Urai, Yushi Hirota, et al.
Frontiers in Immunology|November 30, 2023
Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibodyShin Urai, Miki Watanabe, Hironori Bando, et al.
Hormones (Athens, Greece)|April 16, 2024
Thyroid dysfunction due to trace element deficiency-not only selenium but also zincKohei Nagano, Yuma Motomura, Hironori Bando, et al.
Endocrine Journal|June 8, 2025
Body mass index and metabolic complications in individuals with treatment-naïve acromegalyNaoki Yamamoto, Shin Urai, Masaaki Yamamoto, et al.
Frontiers in Endocrinology|January 7, 2025
Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing's syndromeYasutaka Tsujimoto, Naoki Yamamoto, Hironori Bando, et al.
Journal for Immunotherapy of Cancer|February 28, 2024
Fluctuations in plasma adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitisHironori Bando, Masaaki Yamamoto, Shin Urai, et al.
Pituitary|September 19, 2024
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in JapanYuka Oi-Yo, Masaaki Yamamoto, Shin Urai, et al.
Frontiers in Endocrinology|January 23, 2023
Case report: Late middle-aged features of <i>FAM111A</i> variant, Kenny-Caffey syndrome type 2-suggestive symptoms during a long follow-upYuka Ohmachi, Shin Urai, Hironori Bando, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Endocrine Journal|May 13, 2026
Anti-pituitary-specific transcription factor-1 hypophysitis developing after thymoma resection: a case report with review of literatureHitomi Konishi, Yui Yamashita, Yuma Motomura, et al.
Endocrine|July 22, 2024
Diagnostic dilemma in Cushing's syndrome: discrepancy between patient-reported and physician-assessed manifestationsYuma Motomura, Shin Urai, Hironori Bando, et al.
Diabetology International|January 24, 2024
Type 1 diabetes mellitus affected by potential toxicity from long-term use of nivolumabYuma Motomura, Shin Urai, Yushi Hirota, et al.
Frontiers in Immunology|November 30, 2023
Paraneoplastic isolated adrenocorticotropic hormone deficiency revealed after immune checkpoint inhibitors therapy: new insights into anti-corticotroph antibodyShin Urai, Miki Watanabe, Hironori Bando, et al.
Hormones (Athens, Greece)|April 16, 2024
Thyroid dysfunction due to trace element deficiency-not only selenium but also zincKohei Nagano, Yuma Motomura, Hironori Bando, et al.
Endocrine Journal|June 8, 2025
Body mass index and metabolic complications in individuals with treatment-naïve acromegalyNaoki Yamamoto, Shin Urai, Masaaki Yamamoto, et al.
Frontiers in Endocrinology|January 7, 2025
Metyrapone single administration, as a possible predictive tool of its dosage and timing in Cushing's syndromeYasutaka Tsujimoto, Naoki Yamamoto, Hironori Bando, et al.
Journal for Immunotherapy of Cancer|February 28, 2024
Fluctuations in plasma adrenocorticotropic hormone concentration may predict the onset of immune checkpoint inhibitor-related hypophysitisHironori Bando, Masaaki Yamamoto, Shin Urai, et al.
Pituitary|September 19, 2024
Long-term metabolic effectiveness and safety of growth hormone replacement therapy in patients with adult growth hormone deficiency: a single-institution study in JapanYuka Oi-Yo, Masaaki Yamamoto, Shin Urai, et al.
Frontiers in Endocrinology|January 23, 2023
Case report: Late middle-aged features of <i>FAM111A</i> variant, Kenny-Caffey syndrome type 2-suggestive symptoms during a long follow-upYuka Ohmachi, Shin Urai, Hironori Bando, et al.
Pageof 2